ESMO临床实践指南转移性非小细胞肺癌的诊断治.docx
- 文档编号:2422291
- 上传时间:2022-10-29
- 格式:DOCX
- 页数:9
- 大小:1.01MB
ESMO临床实践指南转移性非小细胞肺癌的诊断治.docx
《ESMO临床实践指南转移性非小细胞肺癌的诊断治.docx》由会员分享,可在线阅读,更多相关《ESMO临床实践指南转移性非小细胞肺癌的诊断治.docx(9页珍藏版)》请在冰豆网上搜索。
ESMO临床实践指南转移性非小细胞肺癌的诊断治
AnnalsofOncologyclinicalpracticeguidelinesTable4.Levelsofevidenceandgradesofrecommendation(adaptedfromtheInfectiousDiseasesSocietyofAmerica-UnitedStatesPublicHealthServiceGradingSystemaLevelsofevidenceIIIIIIIVVEvidencefromatleastonelargerandomised,controlledtrialofgoodmethodologicalquality(lowpotentialforbiasormeta-analysesofwellconductedrandomisedtrialswithoutheterogeneitySmallrandomisedtrialsorlargerandomisedtrialswithasuspicionofbias(lowermethodologicalqualityormeta-analysesofsuchtrialsoroftrialswithdemonstratedheterogeneityProspectivecohortstudiesRetrospectivecohortstudiesorcase–controlstudiesStudieswithoutcontrolgroup,casereports,expertsopinionsGradesofrecommendationABCDEaStrongevidenceforefficacywithasubstantialclinicalbenefit,stronglyrecommendedStrongormoderateevidenceforefficacybutwithalimitedclinicalbenefit,generallyrecommendedInsufficientevidenceforefficacyorbenefitdoesnotoutweightheriskorthedisadvantages(adverseevents,costs,…,optionalModerateevidenceagainstefficacyorforadverseoutcome,generallynotrecommendedStrongevidenceagainstefficacyorforadverseoutcome,neverrecommendedDownloadedfromhttp:
//annonc.oxfordjournals.org/byguestonAugust13,2014BypermissionoftheInfectiousDiseasesSocietyofAmerica[74].Squibb.KKhasreported:
speakers0bureau:
AbbottDiagnostics,Roche,AstraZeneca,EliLilly,Pfizer.SPhasreported:
consultancy/honoraria:
Roche,EliLilly,AstraZeneca,Pfizer,BoehringerIngelheim,Bristol-MyersSquibb,MerckSerono,DaiichiSankyo,Tesaro.DDRhasdeclarednopotentialconflictsofinterest.references1.JemalA,BrayF,CenterMMetal.Globalcancerstatistics.CACancerJClin2011;61:
69–90.2.FieldJK,OudkerkM,PedersenJH,DuffySW.Prospectsforpopulationscreeninganddiagnosisoflungcancer.Lancet2013;382:
732–741.3.MalvezziM,BertuccioP,LeviFetal.Europeancancermortalitypredictionsfortheyear2012.AnnOncol2012;23:
1044–1052.4.InternationalAgencyforResearchonCancer(IARC.http:
//www.iarc.fr/(23May2014,datelastaccessed.5.MalvezziM,BertuccioP,LeviFetal.Europeancancermortalitypredictionsfortheyear2013.AnnOncol2013;24:
792–800.6.WakeleeHA,ChangET,GomezSLetal.Lungcancerincidenceinneversmokers.JClinOncol2007;25:
472–478.7.EdwardsBK,BrownML,WingoPAetal.Annualreporttothenationonthestatusofcancer,1975–2002,featuringpopulation-basedtrendsincancertreatment.JNatlCancerInst2005;97:
1407–1427.8.TohCK,GaoF,LimWTetal.Never-smokerswithlungcancer:
epidemiologicevidenceofadistinctdiseaseentity.JClinOncol2006;24:
2245–2251.9.TravisWD,BrambillaE,NoguchiMetal.InternationalAssociationfortheStudyofLungCancer/AmericanThoracicSociety/EuropeanRespiratorySociety:
internationalmultidisciplinaryclassificationoflungadenocarcinoma:
executivesummary.ProcAmThoracSoc2011;8:
381–385.10.SequistLV,WaltmanBA,Dias-SantagataDetal.GenotypicandhistologicalevolutionoflungcancersacquiringresistancetoEGFRinhibitors.SciTranslMed2011;3:
75ra26.11.KerrKM,BubendorfL,EdelmanMJetal.2ndESMOConsensusConferenceonLungCancer:
pathologyandmolecularbiomarkersfornon-small-celllungcancer.AnnOncol2014June17[epubaheadofprint],doi:
10.1093/annonc/mdu145.12.BesseB,AdjeiA,BaasPetal.2ndESMOConsensusConferenceonLungCancer:
non-small-celllungcancerfirst-line/secondandfurtherlinesoftreatmentinadvanceddisease.AnnOncol2014;25:
1475–1484.13.RekhtmanN,PaikPK,ArcilaMEetal.Clarifyingthespectrumofdriveroncogenemutationsinbiomarker-verifiedsquamouscarcinomaoflung:
lackofEGFR/KRASandpresenceofPIK3CA/AKT1mutations.ClinCancerRes2012;18:
1167–1176.14.KwakEL,BangYJ,CamidgeDRetal.Anaplasticlymphomakinaseinhibitioninnon-small-celllungcancer.NEnglJMed2010;363:
1693–1703.15.ShawAT,YeapBY,Mino-KenudsonMetal.Clinicalfeaturesandoutcomeofpatientswithnon-small-celllungcancerwhoharborEML4-ALK.JClinOncol2009;27:
4247–4253.16.WuY,LiP,ZhangHetal.Diagnosticvalueoffluorine18fluorodeoxyglucosepositronemissiontomography/computedtomographyforthedetectionofmetastasesinnon-small-celllungcancerpatients.IntJCancer2013;132:
E37–E47.17.EisenhauerEA,TherasseP,BogaertsJetal.Newresponseevaluationcriteriainsolidtumours:
revisedRECISTguideline(version1.1.EurJCancer2009;45:
228–247.18.BaserS,ShannonVR,EapenGAetal.Smokingcessationafterdiagnosisoflungcancerisassociatedwithabeneficialeffectonperformancestatus.Chest2006;130:
1784–1790.19.HughesAN,O’BrienME,PettyWJetal.OvercomingCYP1A1/1A2mediatedinductionofmetabolismbyescalatingerlotinibd
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- ESMO 临床 实践 指南 转移性 细胞 肺癌 诊断
![提示](https://static.bdocx.com/images/bang_tan.gif)